Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa

Journal of Medical Virology

Volumn 83, Issue 6, 2011, Pages 929-934

  Barth, Roos E ^a   Huijgen, Quirine ^a   Tempelman, Hugo A ^b   Mudrikova, Tania ^a   Wensing, Annemarie M J ^a   Hoepelman, Andy I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Ndlovu Medical Centre   (South Africa)

Author keywords

HBV DNA; Hepatitis B; Hepatitis C; Human immunodeficiency virus; Occult infection; Sub Saharan Africa

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE ACTIVITY; ETHNIC DIFFERENCE; FEMALE; GROUPS BY AGE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NETHERLANDS; NONHUMAN; OCCULT INFECTION; PREDICTOR VARIABLE; RURAL AREA; SERODIAGNOSIS; SEROPREVALENCE; SEX DIFFERENCE; SOUTH AFRICA; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DNA, VIRAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; PREVALENCE; RNA, VIRAL; RURAL POPULATION; SOUTH AFRICA; VIRAL LOAD;

HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79954605832     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22026     Document Type: Article

References (40)

1. Abdool Karim SS, Thejpal R, Singh B. 1989. High prevalence of hepatitis B virus infection in rural black adults in Mseleni, South Africa. Am J Public Health 79:893-894.
2. Barth RE, van der Meer JT, Hoepelman AI, Schrooders PA, van de Vijver DA, Geelen SP, Tempelman HA. 2008. Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. Eur J Clin Microbiol Infect Dis 2:977-984.
3. Barth RE, Huigen Q, Taljaard J, Hoepelman AIM. 2010. Hepatitis B/C and HIV in Sub-Saharan Africa: An association between highly prevalent infectious diseases. A systematic review and meta-analysis. Int J Infect Dis 14:1024-1031.
4. British HIV Association. 2010. Guidelines for the management of coinfection with HIV-1 and hepatitis B or C virus. Available at.
5. Burnett RJ, Francois G, Kew MC, Leroux-Roels G, Meheus A, Hoosen AA, Mphahlele MJ. 2005. Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: A call for further investigation. Liver Int 25:201-213.
6. Burnett RJ, Ngobeni JM, Francois G, Hoosen AA, Leroux-Roels G, Meheus A, Mphahlele MJ. 2007. Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 18:152-156.
7. CDC. 2006. Prevalence of chronic infection with hepatitis B virus. Available at.
8. Chen TY, Ding EL, Seage Iii GR, Kim AY. 2009. Meta-analysis: Increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 49:1605-1615.
9. Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. 2009. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. J Med Virol 81:441-445.
10. Cooper CL, Mills E, Wabwire BO, Ford N, Olupot-Olupot P. 2009. Chronic viral hepatitis may diminish the gains of HIV antiretroviral therapy in sub-Saharan Africa. Int J Infect Dis 13:302-306.
11. den Brinker M, Wit FW, Wertheim-van Dillen PM, Jurriaans S, Weel J, van Leeuwen R, Pakker NG, Reiss P, Danner SA, Weverling GJ, Lange JM. 2000. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection. AIDS 14:2895-2902.
12. EACS. 2009. Guidelines clinical management and treatment of chronic hepatitis B and C co-infection in HIV-infected adults. Available at.
13. Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, Maskew M, Di Bisceglie A, MacPhail P, Sanne I, Kew M. 2009. Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis 13:488-492.
14. Harania RS, Karuru J, Nelson M, Stebbing J. 2008. HIV, hepatitis B and hepatitis C coinfection in Kenya. AIDS 22:1221-1222.
15. Hoffmann CJ, Thio CL. 2007. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7:402-409.
16. Hoffmann CJ, Charalambous S, Thio CL, Martin DJ, Pemba L, Fielding KL, Churchyard GJ, Chaisson RE, Grant AD. 2007. Hepatotoxicity in an African antiretroviral therapy cohort: The effect of tuberculosis and hepatitis B. AIDS 21:1301-1308.
17. Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, Chaisson RE, Grant AD, Fielding KL, Thio CL. 2008. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 47:1479-1485.
18. Kellerman SE, Hanson DL, McNaghten AD, Fleming PL. 2003. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 188:571-577.
19. Kew MC. 1996. Progress towards the comprehensive control of hepatitis B in Africa: A view from South Africa. Gut 38:S31-S36.
20. Lo Re V, Frank I, 3rd, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL. 2007. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 44:315-320.
21. Lodenyo H, Schoub B, Ally R, Kairu S, Segal I. 2000. Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg. East Afr Med J 77:13-15.
22. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. 2009. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol 81:406-412.
23. Madhava V, Burgess C, Drucker E. 2002. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2:293-302.
24. Marcellin P. 2009. Hepatitis B and hepatitis C in 2009. Liver Int 29:1-8.
25. Modi AA, Feld JJ. 2007. Viral hepatitis and HIV in Africa. AIDS Rev 9:25-39.
26. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM. 2006. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 35:14-20.
27. Nagu TJ, Bakari M, Matee M. 2008. Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 8:416.
28. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, Kalapothaki V, Hatzakis A. 2009. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: A cohort study and meta-analysis. Clin Infect Dis 48:1763-1771.
29. Parboosing R, Paruk I, Lalloo UG. 2008. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naive patients is associated with renal insufficiency and increased mortality. J Med Virol 80:1530-1536.
30. Pas SD, Fries E, De Man RA, Osterhaus AD, Niesters HG. 2000. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays. J Clin Microbiol 38:2897-2901.
31. Raimondo G, Pollicino T, Cacciola I, Squadrito G. 2007. Occult hepatitis B virus infection. J Hepatol 46:160-170.
32. Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ, Sherman KE. 2007. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 44:309-314.
33. Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, Mauss S, Brau N, Hatzakis A, Pol S, Rockstroh J. 2007. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 21:1073-1089.
34. Soriano V, Puoti M, Peters M, Benhamou Y, Sulkowski M, Zoulim F, Mauss S, Rockstroh J. 2008. Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS 22:1399-1410.
35. Sulkowski MS, Thomas DL, Mehta SH, Chaisson RE, Moore RD. 2002. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: Role of hepatitis C and B infections. Hepatology 35:182-189.
36. Thio CL. 2009. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 49:S138-S145.
37. Thomson EC, Main J. 2008. Epidemiology of hepatitis C virus infection in HIV-infected individuals. J Viral Hepat 15:773-781.
38. Torbenson M, Thomas DL. 2002. Occult hepatitis B. Lancet Infect Dis 2:479-486.
39. WHO. 2002. Hepatitis B. Department of communicable diseases surveillance and response. Accessed at.
40. WHO. 2007. Sub-Saharan Africa. AIDS epidemic update Regional Summary. Accessed at.